Filing Details
- Accession Number:
- 0001415889-22-011186
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2022-11-08 16:34:22
- Reporting Period:
- 2022-11-04
- Accepted Time:
- 2022-11-08 16:34:22
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 815094 | Abiomed Inc | NASD | Surgical & Medical Instruments & Apparatus (3841) | 042743260 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1821352 | A Marc Began | C/O Abiomed, Inc., 22 Cherry Hill Drive Danvers MA 01923 | Vp & General Counsel | No | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock, $0.01 Par Value | Disposition | 2022-11-04 | 2,000 | $373.71 | 13,785 | No | 4 | S | Direct | |
| Common Stock, $0.01 Par Value | Disposition | 2022-11-05 | 1,548 | $373.99 | 12,237 | No | 4 | F | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct | |
| No | 4 | F | Direct |
Reported Derivative Holdings
| Sec. Name | Sec. Type | Price | Date | Expiration Date | Amount | Remaning Holdings | Nature of Ownership |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock Option (Right to Buy) | $266.39 | 2020-05-30 | 2029-05-30 | 0 | 7,000 | Direct |
| Common Stock | Stock Option (Right to Buy) | $223.90 | 2021-05-29 | 2030-05-29 | 0 | 5,125 | Direct |
| Common Stock | Stock Option (Right to Buy) | $283.88 | 2022-05-25 | 2031-05-25 | 0 | 2,961 | Direct |
| Expiration Date | Amount | Remaning Holdings | Nature of Ownership |
|---|---|---|---|
| 2029-05-30 | 0 | 7,000 | Direct |
| 2030-05-29 | 0 | 5,125 | Direct |
| 2031-05-25 | 0 | 2,961 | Direct |
Footnotes
- Sale of common stock pursuant to reporting owner's 10b5-1 plan.
- This price represents the sale price of the transactions on the reported date at $373.7100. Detailed information regarding the number of shares sold at each separate price will be provided upon request by the Commission staff, the Issuer, or a security holder of the Issuer.
- Transaction represents shares of common stock withheld solely for the payment of withholding tax liability associated with the vesting of awards of restricted stock units in accordance with the time periods set forth in such awards.
- Grant to reporting person of option to buy the number of shares of Common Stock set forth in Table II, Column 7, under the ABIOMED, Inc. 2015 Omnibus Incentive Plan.
- These options become exercisable in annual 33-1/3% increments, commencing on the date shown in Table II, Column 6.
Billionaire Hedge Funds
